According to Weilizhibo-B's announcement, Dr. Kang Xiaoqiang, Chairman, Executive Director, CEO and General Manager of the company, based on recognition of the company's value and confidence in future overall business development and growth potential, plans to acquire and increase the company's H shares in the open market within about 6 months from the date of this announcement. The total cost of the increase is expected to not exceed HK$20 million. As of the date of this announcement, Dr. Kang owns or is deemed to have an interest in a total of 295.03 million H shares, accounting for about 14.92% of the issued H shares and about 14.83% of the company's total issued share capital.

Zhitongcaijing · 2d ago
According to Weilizhibo-B's announcement, Dr. Kang Xiaoqiang, Chairman, Executive Director, CEO and General Manager of the company, based on recognition of the company's value and confidence in future overall business development and growth potential, plans to acquire and increase the company's H shares in the open market within about 6 months from the date of this announcement. The total cost of the increase is expected to not exceed HK$20 million. As of the date of this announcement, Dr. Kang owns or is deemed to have an interest in a total of 295.03 million H shares, accounting for about 14.92% of the issued H shares and about 14.83% of the company's total issued share capital.